Table 2.

Logistic regression analysis of response and progression rate in the ICIs alone group

	Response	Progression
Parameters	Odds ratio (OR); 95% CI; p value
PD-L1	1.04 (0.97–1.10); p = 0.292	0.97 (0.89–1.05); p = 0.40
HGF baseline (pg/ml)	0.87 (0.77–0.99); p = 0.04	1.17 (1.02–1.35); p = 0.03
HGF first evaluation	0.80 (0.514–1.24); p = 0.312	0.97 (0.59–1.58); p = 0.90
PS < 1	4.73 (0.144–155.47); p = 0.38	0.37 (0.002–64.12); p = 0.71
Histology (adenocarcinoma, ADK)	0.02 (0.001–0.62); p = 0.03	31.65 (1.05–949.11); p = 0.05
Metastasis < 2	6.84 (0.27–170.93); p = 0.24	8.98 (0.17–473.93); p = 0.28
Presence of a mutation	0.02 (0.0003–1.769); p = 0.009	173.47 (0.19–161,045.95); p = 0.14